↓ Skip to main content

Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 198)
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet
twitter
8 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?
Published in
Journal of Pharmaceutical Policy and Practice, November 2018
DOI 10.1186/s40545-018-0156-8
Pubmed ID
Authors

Rena M. Conti, Kevin H. Nguyen, Meredith B. Rosenthal

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 26%
Other 5 22%
Researcher 3 13%
Student > Doctoral Student 3 13%
Student > Ph. D. Student 2 9%
Other 1 4%
Unknown 3 13%
Readers by discipline Count As %
Nursing and Health Professions 4 17%
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Social Sciences 3 13%
Economics, Econometrics and Finance 2 9%
Business, Management and Accounting 1 4%
Other 3 13%
Unknown 6 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2020.
All research outputs
#1,246,467
of 14,983,162 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#21
of 198 outputs
Outputs of similar age
#50,231
of 381,508 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#5
of 31 outputs
Altmetric has tracked 14,983,162 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 198 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,508 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.